Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study
The Breast Journal Nov 18, 2017
Lago V, et al. - The 10-year oncologic safety of nipple-sparing mastectomy (NSM) in patients diagnosed with ductal carcinoma in situ (DCIS) was determined. NSM is a realistic option of treatment in patients with DCIS that are not candidates to breast-conserving therapy.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
